References
- Andersen ES, Knudsen A, Rix P, Johansen B (2003). Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol, 90, 109-12. https://doi.org/10.1016/S0090-8258(03)00192-6
- Ashrafgangooei T, Rezaeezadeh M (2011). Risk of malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev, 12, 1727-30.
- Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet, 70, 209-62. https://doi.org/10.1016/S0020-7292(00)90001-8
- Bouzari Z, Yazdani S, Ahmadi MH, et al (2011). Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses. BMC Res Notes, 4, 206. https://doi.org/10.1186/1756-0500-4-206
- Chia YN, Marsden DE, Robertson G, Hacker NF (2008). Triage of ovarian masses. Aust N Z J Obstet Gynaecol, 48, 322-8. https://doi.org/10.1111/j.1479-828X.2008.00825.x
- Davies AP, Jacobs IJ, Woolas R, Fish A, Oram D (1993). The adnexal mass: benign or malignant? Evaluation of a risk ofmalignancy index. Br J Obstet Gynaecol, 100, 927-31. https://doi.org/10.1111/j.1471-0528.1993.tb15109.x
- Ekerhovd E, Wienerroith H, Staudach A, Granberg S (2001). Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imagingand histopathologic diagnosis. Am J Obstet Gynecol, 18, 48-54.
- Engelen MJ, Kos HE, Willemse PH, et al (2006). Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer, 106, 589-98. https://doi.org/10.1002/cncr.21616
- Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC (1988). Comparison of serum CA125, clinical impressionand ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol, 72, 659-64.
- Fiorca JV, Roberts WS (1996). Screening for ovarian cancer. Cancer Control, 3, 120-9.
- Geomini P, Kruitwagen R, Bremer G, Cnossen J, Mol B (2009). The accuracy of risk scores in predicting ovarian malignancy: a systematic review. Obstet Gynecol, 113, 384-94. https://doi.org/10.1097/AOG.0b013e318195ad17
- Iyer VR, Lee SI (2010). MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol, 194, 311-21. https://doi.org/10.2214/AJR.09.3522
- Jacobs I, Oram D, Fairbanks J, et al (1990). A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol, 97, 922-9. https://doi.org/10.1111/j.1471-0528.1990.tb02448.x
- Landis SH, Murray T, Bolden 5, Wingo PA (1999). Cancer statistics. CA Cancer J Clin, 49, 8-31. https://doi.org/10.3322/canjclin.49.1.8
- Ma S, Shen K, Lang J. (2003). A risk of malignancy index in preoperative diagnosis of ovarian cancer. Chin Med J (Engl), 116, 396-9.
- Manjunath AP, Pratapkumar, Sujatha K, Vani R (2001). Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol, 81, 225-9. https://doi.org/10.1006/gyno.2001.6122
- Meray O, Turkcuoglu I, Meydanli MM, Kafkasli A (2010). Risk of malignancy index is not sensitive in detecting nonepithelial ovarian cancer and borderline ovarian tumor. J Turkish German Gynecol Assoc, 11, 22-6.
- Obeidat BR, Amarin ZO, Latimer JA, Crawford RA (2004). Risk of malignancy index in the preoperative evaluation of pelvic masses. Int J Gynaecol Obstet, 85, 255-8. https://doi.org/10.1016/j.ijgo.2003.10.009
- Ong C, Biswas A, Choolani M, Low JJ (2013). Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population. Singapore Med J, 54, 136-9.
- Osmers RG, Osmers M, von Maydell B, Wagner B, Kuhn W (1998). Evaluation of ovarian tumors in postmenopausal women by transvaginal sonography. Eur J Obstet Gynecol Reprod Biol, 77, 81-8. https://doi.org/10.1016/S0301-2115(97)00235-2
- Rossi A, Braghin C, Soldano F, Isola M, et al (2011). A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS). Eur J Obstet Gynecol Reprod Biol, 157, 84-8. https://doi.org/10.1016/j.ejogrb.2011.02.009
- Tanriverdi HA, Sade H, Akbulut V, Barut A, Bayar U (2007). Clinical and ultrasonographic evaluation of pelvic masses. J Turkish-German Gynecol Assoc, 8, 67-70.
- Tingulstad S, Hagen B, Skjeldestad FE, et al (1999). The riskof-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol, 93, 448-52. https://doi.org/10.1016/S0029-7844(98)00433-5
- Tingulstad S, Hagen B, Skjeldestad FE, et al (1996). Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the preoperative diagnosis of pelvic masses. Br J Obstet Gynaecol, 103, 826-31. https://doi.org/10.1111/j.1471-0528.1996.tb09882.x
- Valentin L (2004). Use of morphology to characterize and manage common adnexal masses. Best Pract Res Clin Obstet Gynaecol, 18, 71-89. https://doi.org/10.1016/j.bpobgyn.2003.10.002
- Van den Akker PA, Zusterzeel PL, Aalders AL, et al (2011). external validation of the adapted risk of malignancy index incorporating tumor size in the preoperative evaluation of adnexal masses. Eur J Obstet Gynecol Reprod Biol, 159, 422-5. https://doi.org/10.1016/j.ejogrb.2011.07.035
- Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T (2009). Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol, 144, 163-7. https://doi.org/10.1016/j.ejogrb.2009.02.048
- Yavuzcan A, Baloglu A, Cetinkaya B (2009). The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Arch Gynecol Obstet, 280, 939-44. https://doi.org/10.1007/s00404-009-1038-8
- Yavuzcan A, Caglar M, Ozgu E, et al (2013). Should cutoff values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations? Asian Pac J Cancer Prev, 14, 5455-9. https://doi.org/10.7314/APJCP.2013.14.9.5455
Cited by
- Improved Diagnostic Accuracy in Characterization of Adnexal Masses by Detection of Choline Peak Using 1H MR Spectroscopy in Comparison to Internal Reference at 3 Tesla vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5085
- Differentiation of Benign from Malignant Adnexal Masses by Functional 3 Tesla MRI Techniques: Diffusion-Weighted Imaging and Time-Intensity Curves of Dynamic Contrast-Enhanced MRI vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3407
- IOTA Simple Rules in Differentiating between Benign and Malignant Adnexal Masses by Non-expert Examiners vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3835
- Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2177